118 related articles for article (PubMed ID: 3677360)
21. Epicardial mapping of polymorphous ventricular tachycardias induced in the canine heart with procainamide.
Murakawa Y; Inoue H; Toda I; Nozaki A; Kawakubo K; Sugimoto T
Am Heart J; 1988 May; 115(5):1037-42. PubMed ID: 3364336
[TBL] [Abstract][Full Text] [Related]
22. Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo.
Anderson KP; Walker R; Dustman T; Lux RL; Ershler PR; Kates RE; Urie PM
Circulation; 1989 Apr; 79(4):948-58. PubMed ID: 2924420
[TBL] [Abstract][Full Text] [Related]
23. Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration.
Marchlinski FE; Buxton AE; Josephson ME; Schmitt C
Circulation; 1989 Jan; 79(1):39-46. PubMed ID: 2910546
[TBL] [Abstract][Full Text] [Related]
24. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
25. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME
Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
[TBL] [Abstract][Full Text] [Related]
26. Rate-dependent [K+](o) accumulation in canine right atria in vivo: electrophysiological consequences.
Miyata A; Dowell JD; Zipes DP; Rubart M
Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H506-17. PubMed ID: 12124195
[TBL] [Abstract][Full Text] [Related]
27. Use-dependent effects of lidocaine on conduction in canine myocardium: application of the modulated receptor hypothesis in vivo.
Davis J; Matsubara T; Scheinman MM; Katzung B; Hondeghem LH
Circulation; 1986 Jul; 74(1):205-14. PubMed ID: 2423270
[TBL] [Abstract][Full Text] [Related]
28. Procainamide and retrograde atrioventricular nodal conduction in man.
Shenasa M; Gilbert CJ; Schmidt DH; Akhtar M
Circulation; 1982 Feb; 65(2):355-62. PubMed ID: 7053895
[TBL] [Abstract][Full Text] [Related]
29. Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction.
Morady F; DiCarlo LA; Baerman JM; Krol RB
J Am Coll Cardiol; 1985 Jul; 6(1):179-85. PubMed ID: 4008772
[TBL] [Abstract][Full Text] [Related]
30. Interaction between potassium concentration and inhibition of myocardial Na(+)-K(+)-ATPase by two class 1A antiarrhythmic drugs: quinidine and procainamide.
Dzimiri N; Almotrefi AA
Arch Int Pharmacodyn Ther; 1991; 314():34-43. PubMed ID: 1668603
[TBL] [Abstract][Full Text] [Related]
31. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
[TBL] [Abstract][Full Text] [Related]
32. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
Patterson E; Scherlag BJ; Berlin KD; Lazzara R
J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
[TBL] [Abstract][Full Text] [Related]
33. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.
Toy W; Sasyniuk BI
J Pharmacol Exp Ther; 1990 Aug; 254(2):603-11. PubMed ID: 2166798
[TBL] [Abstract][Full Text] [Related]
34. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
Derakhchan K; Pagé P; Lambert C; Kus T
J Pharmacol Exp Ther; 1994 Jul; 270(1):47-54. PubMed ID: 8035342
[TBL] [Abstract][Full Text] [Related]
35. Beta-adrenergic modulation of fast inward sodium current in canine myocardium. Syncytial preparations versus isolated myocytes.
Gintant GA; Liu DW
Circ Res; 1992 Apr; 70(4):844-50. PubMed ID: 1312913
[TBL] [Abstract][Full Text] [Related]
36. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
Valois M; Sasyniuk BI
Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
[TBL] [Abstract][Full Text] [Related]
37. The human atrial strength-interval relation. Influence of cycle length and procainamide.
Buxton AE; Marchlinski FE; Miller JM; Morrison DF; Frame LH; Josephson ME
Circulation; 1989 Feb; 79(2):271-80. PubMed ID: 2914346
[TBL] [Abstract][Full Text] [Related]
38. Canine electrocardiographic and cardiac electrophysiologic changes induced by procainamide.
Rosen MR; Gelband H; Hoffman BF
Circulation; 1972 Sep; 46(3):528-36. PubMed ID: 5071738
[No Abstract] [Full Text] [Related]
39. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
40. Interactions of halothane with isoproterenol and epinephrine on canine epicardial conduction velocity at normal and elevated potassium levels.
Camara AK; Turner LA; Bosnjak ZJ
Acta Anaesthesiol Scand; 2001 Aug; 45(7):885-92. PubMed ID: 11472292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
